Loss-of-function assays showed that knockdown of ZFAS1-inhibited NSCLC cell proliferation and invasive potentials increased the rate of apoptosis of NSCLC cells in vitro and attenuated tumour growth of NSCLC cells in nude mice [53]. The gene discussed is ZFAS1; the disease is neoplasm.